• -
  • English
  • Japanese
  • Korean
首頁 > 出版商一覽 > GBI Research
出版商
出版商指數
從類別尋找
從地區尋找

GBI Research 市場調查資料一覽

日商環球訊息有限公司為GBI Research所發行的研究報告代理商, 考慮購買或需要諮詢研究報告時請與我們聯絡。≫ 選擇本公司購買的優點

GBI Research
GBI Research發行對於醫藥品、醫療機器、替代能源、發電、清淨技術、石油・瓦斯、化學品等、廣泛專門業界的詳細資訊報告書。本報告書依據完整的第一次・第二次調查、獨自的資料庫、及公司內部・公司外部的專家團隊高品質分析製作而成。企業・國家・產業等級的洞察和分析部分、包含競爭企業和市場資料、評價、臨床・市場趨勢、產品生產線及預測。
關於這個網站未刊載的報告書
篩選
標題搜索
結果共123個,以下為1 - 25 排序依 每頁數量
COPD Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies
COPD Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies
出版商
GBI Research
商品編碼
423017
出版日期
2017年01月01日
內容資訊
122 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations
Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations
出版商
GBI Research
商品編碼
410321
出版日期
2016年12月01日
內容資訊
65 Pages
價格
USD 6,995 Sample Availavle Browse Availavle
Global Cancer Immunotherapies Market to 2022 - Immune Checkpoint Inhibitors and Therapeutic Cancer Vaccines to Characterize Increasingly Competitive Market
Global Cancer Immunotherapies Market to 2022 - Immune Checkpoint Inhibitors and Therapeutic Cancer Vaccines to Characterize Increasingly Competitive Market
出版商
GBI Research
商品編碼
410320
出版日期
2016年12月01日
內容資訊
363 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects
Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects
出版商
GBI Research
商品編碼
409707
出版日期
2016年12月01日
內容資訊
88 Pages
價格
USD 6,995 Sample Availavle Browse Availavle
Diabetes & Obesity Drug Development Pipeline Review, 2016
Diabetes & Obesity Drug Development Pipeline Review, 2016
出版商
GBI Research
商品編碼
397899
出版日期
2016年12月01日
內容資訊
560 Pages
價格
USD 3,995 Sample Availavle Browse Availavle
Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2022 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline
Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2022 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline
出版商
GBI Research
商品編碼
336890
出版日期
2016年12月01日
內容資訊
110 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments
Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments
出版商
GBI Research
商品編碼
219212
出版日期
2016年12月01日
內容資訊
133 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19
Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19
出版商
GBI Research
商品編碼
399713
出版日期
2016年11月01日
內容資訊
183 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation
出版商
GBI Research
商品編碼
399712
出版日期
2016年11月01日
內容資訊
61 Pages
價格
USD 6,995 Sample Availavle Browse Availavle
Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy
Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy
出版商
GBI Research
商品編碼
399711
出版日期
2016年11月01日
內容資訊
126 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Ophthalmology Drug Development Pipeline Review, 2016
Ophthalmology Drug Development Pipeline Review, 2016
出版商
GBI Research
商品編碼
397898
出版日期
2016年11月01日
內容資訊
633 Pages
價格
USD 3,995 Sample Availavle Browse Availavle
Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth
Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth
出版商
GBI Research
商品編碼
388271
出版日期
2016年10月01日
內容資訊
192 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape
Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape
出版商
GBI Research
商品編碼
381440
出版日期
2016年09月13日
內容資訊
161 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way
Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way
出版商
GBI Research
商品編碼
388270
出版日期
2016年09月01日
內容資訊
70 Pages
價格
USD 6,995 Sample Availavle Browse Availavle
Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies
Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies
出版商
GBI Research
商品編碼
374467
出版日期
2016年09月01日
內容資訊
112 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation
Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation
出版商
GBI Research
商品編碼
372574
出版日期
2016年09月01日
內容資訊
73 Pages
價格
USD 6,995 Sample Availavle Browse Availavle
Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2022 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth
Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2022 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth
出版商
GBI Research
商品編碼
369233
出版日期
2016年08月01日
內容資訊
176 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way
Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way
出版商
GBI Research
商品編碼
369232
出版日期
2016年08月01日
內容資訊
202 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes
Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes
出版商
GBI Research
商品編碼
369231
出版日期
2016年08月01日
內容資訊
68 Pages
價格
USD 6,995 Sample Availavle Browse Availavle
Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment
Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment
出版商
GBI Research
商品編碼
367993
出版日期
2016年08月01日
內容資訊
100 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation
Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation
出版商
GBI Research
商品編碼
367992
出版日期
2016年08月01日
內容資訊
66 Pages
價格
USD 6,995 Sample Availavle Browse Availavle
Global Ophthalmology Drugs Market to 2022 - Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period
Global Ophthalmology Drugs Market to 2022 - Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period
出版商
GBI Research
商品編碼
367991
出版日期
2016年08月01日
內容資訊
150 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Osteoporosis Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Anabolic Therapies
Osteoporosis Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Anabolic Therapies
出版商
GBI Research
商品編碼
366603
出版日期
2016年07月04日
內容資訊
131 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics
Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics
出版商
GBI Research
商品編碼
363981
出版日期
2016年06月16日
內容資訊
143 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Frontier Pharma: Diabetic Complications - Innovative and Diverse Neuropathies, Nephropathy and Retinopathies Pipelines Demonstrate Shift Towards Disease Modifying Therapies
Frontier Pharma: Diabetic Complications - Innovative and Diverse Neuropathies, Nephropathy and Retinopathies Pipelines Demonstrate Shift Towards Disease Modifying Therapies
出版商
GBI Research
商品編碼
363980
出版日期
2016年06月01日
內容資訊
73 Pages
價格
USD 6,995 Sample Availavle Browse Availavle